Research Reports
Emcure Pharmaceuticals Shares
Emcure Pharmaceuticals company logo

Emcure Pharmaceuticals

DMAT
PUBLIC LIMITED

Price Chart

1W
1M
1Y
MAX
High

-

Low

-

Return

-

No data available

Emcure Pharmaceuticals Essentials

As of April 03, 2026, Emcure Pharmaceuticals Ltd, Listed Shares are trading at ₹1,510.00 per share.
ISIN
info icon
INE168P01015
Face Value
info icon
10
Total Shares
info icon
18,11,52,116
Market Cap
info icon
27,353.97 Cr
Profit After Tax
info icon
527.58 Cr
Total Revenue
info icon
6,671.57 Cr
P/E
info icon
54.83
P/B
info icon
9.48
Sector
info icon
Health Care
Sub-sector
info icon
Pharmaceuticals
Category
info icon
Listed
Cashflow - Operations
info icon
1,097.24 Cr

About Emcure Pharmaceuticals

Company Overview:

  • Emcure was incorporated by Mr. Satish Mehta in 1981; the company commenced operations in 1983 in Pune, Maharashtra.
  • Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
  • The group has 13 manufacturing facilities across India and 5 R&D center's. The manufacturing facilities can manufacture pharmaceutical and biopharmaceutical products across a wide range of dosage forms, including oral solids, oral liquids, injectables, including liposomal and lyophilized injectables, biotherapeutics and complex APIs.
  • Emcure is an R&D driven company and their core strength lies in their ability to research, develop and manufacture in house specialty pharmaceutical products for high-growth therapeutic areas, for which there is limited competition and high barriers to entry.
  • Target market across 70 countries, with a strong presence in INDIA, Europe and Canada.
  • Emcure Pharmaceuticals sales in India contributed 53.16% of their total revenue from operation and rest 46.84% outside of India in FY2023.
  • As of September 30, 2023, Emcure had been granted 201 patents and had 33 pending patent applications in several countries, and had submitted 102 DMFs for APIs with the USFDA.

Want to See a Detailed Investment Analysis?

Explore in-depth financial analysis, performance metrics, and key disclosures.

Emcure Pharmaceuticals Media

News
Articles
Videos
Emcure Pharma inaugurates R&D centre in Ahmedabad
Emcure Pharma inaugurates R&D centre in Ahmedabad
22 Jan 2025
Express Pharma
Emcure Pharma Brings product range for menopause wellness
Emcure Pharma Brings product range for menopause wellness
04 Sep 2024
The Economic Times
Emcure Pharma Partners With Moms To Normalize Public Breastfeeding For World Breastfeeding Week
Emcure Pharma Partners With Moms To Normalize Public Breastfeeding For World Breastfeeding Week
01 Aug 2024
BW Healthcare

Emcure Pharmaceuticals

₹ 1,510

cartIcon